Trial Profile
A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 17 Sep 2005 New trial record.